Literature DB >> 12810939

Bone health in patients with fibromyalgia.

A W Al-Allaf1, P A Mole, C R Paterson, T Pullar.   

Abstract

OBJECTIVES: To determine whether women with fibromyalgia are at increased risk of developing osteoporosis or osteomalacia.
METHODS: Forty premenopausal women with fibromyalgia and 37 age-matched female controls were studied. Broadband ultrasound attenuation (BUA) and velocity of sound (VOS) were measured at the calcaneum and bone mineral density was measured at the forearm and lumbar spine using dual-energy X-ray absorptiometry. Serum calcium, alkaline phosphatase, gamma-glutamyl transferase, 25-hydroxyvitamin D and plasma viscosity were measured in all subjects and parathyroid hormone was measured in subjects recruited in the latter part of the study.
RESULTS: Seventeen patients with fibromyalgia syndrome and seven controls had 25-hydroxyvitamin D concentrations <20 nmol/l (P < 0.015) and in three FMS patients serum parathyroid hormone was raised. Bone density in fibromyalgia patients was slightly lower at the mid-distal forearm but comparable to that in controls at other sites.
CONCLUSIONS: There is no reason to recommend routine bone densitometry in fibromyalgia patients. However, vitamin D subnutrition is common in these patients and this should be sought.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12810939     DOI: 10.1093/rheumatology/keg356

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  17 in total

1.  Effects of Vitamin D Therapy on Quality of Life in Patients with Fibromyalgia.

Authors:  Atalay Dogru; Ayse Balkarli; Veli Cobankara; Sevket Ercan Tunc; Mehmet Sahin
Journal:  Eurasian J Med       Date:  2017-06

Review 2.  The role of vitamin D in pathophysiology and treatment of fibromyalgia.

Authors:  Carlos A S Jesus; David Feder; Mario F P Peres
Journal:  Curr Pain Headache Rep       Date:  2013-08

Review 3.  Fibromyalgia and nutrition, what do we know?

Authors:  Laura-Isabel Arranz; Miguel-Angel Canela; Magda Rafecas
Journal:  Rheumatol Int       Date:  2010-04-01       Impact factor: 2.631

4.  Association between low bone mineral density and fibromyalgia: a meta-analysis.

Authors:  Young Ho Lee; Gwan Gyu Song
Journal:  Clin Rheumatol       Date:  2017-05-23       Impact factor: 2.980

Review 5.  Bone mineral density is decreased in fibromyalgia syndrome: a systematic review and meta-analysis.

Authors:  Sikarin Upala; Wai Chung Yong; Anawin Sanguankeo
Journal:  Rheumatol Int       Date:  2016-12-05       Impact factor: 2.631

6.  Efficacy and safety of weekly vitamin D3 in patients with fibromyalgia: 12-week, double-blind, randomized, controlled placebo trial.

Authors:  Luis Iván Lozano-Plata; David Vega-Morales; Jorge Antonio Esquivel-Valerio; Mario Alberto Garza-Elizondo; Dionicio A Galarza-Delgado; Karina Silva-Luna; Griselda Serna-Peña; Janeth Sifuentes-Ramírez; Alfredo de Jesús Garza-Guerra; Raúl Díaz-Niño de Rivera
Journal:  Clin Rheumatol       Date:  2021-02-10       Impact factor: 2.980

7.  Bone mass and vitamin D levels in women with a diagnosis of fibromyalgia.

Authors:  F Mateos; C Valero; J M Olmos; B Casanueva; J Castillo; J Martínez; J L Hernández; J González Macías
Journal:  Osteoporos Int       Date:  2013-09-06       Impact factor: 4.507

8.  Vitamin D deficiency is associated with anxiety and depression in fibromyalgia.

Authors:  D J Armstrong; G K Meenagh; I Bickle; A S H Lee; E-S Curran; M B Finch
Journal:  Clin Rheumatol       Date:  2006-07-19       Impact factor: 2.980

9.  Perioperative Serum 25-Hydroxyvitamin D Levels as a Predictor of Postoperative Opioid Use and Opioid Use Disorder: a Cohort Study.

Authors:  Yuhree Kim; Fang Zhang; Katherine Su; Marc LaRochelle; Matthew Callahan; David Fisher; J Frank Wharam; Maryam M Asgari
Journal:  J Gen Intern Med       Date:  2020-06-24       Impact factor: 5.128

Review 10.  Not enough vitamin D: health consequences for Canadians.

Authors:  Gerry Schwalfenberg
Journal:  Can Fam Physician       Date:  2007-05       Impact factor: 3.275

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.